Anebulo Pharmaceuticals financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

NASDAQ:ANEB · Nasdaq · Healthcare · sector #13

$0.3200-11.11%

2026-10-05 close · prelim

Anebulo Pharmaceuticals's published financial data is dated 2026-10-04. 2025 revenue was $0M. 2025 operating profit was −$9M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy